skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Transfusion-associated graft-versus-host disease

Journal Article · · Yale Journal of Biology and Medicine; (USA)
OSTI ID:5839612
 [1]
  1. Yale Univ. School of Medicine, New Haven, CT (USA)

The clinical pathologic syndrome of graft-versus-host disease (GVHD) is usually a sequela of bone marrow transplantation. This disorder occurs as a result of recognition by engrafted donor-derived lymphocytes of foreign recipient transplantation antigens. GVHD may also result from engraftment of lymphocytes from other sources, including (1) transfusion of lymphocytes containing blood components, (2) transplacental maternal fetal transfusion, and (3) passive transfer of lymphocytes in solid organ transplantation. The recipients are usually severely immunodeficient and thus incapable of rejecting the transfused lymphocytes. This syndrome may, however, also develop in immunologically competent patients receiving blood products from individuals with histocompatibility antigens not recognized as foreign. 58 refs.

OSTI ID:
5839612
Journal Information:
Yale Journal of Biology and Medicine; (USA), Vol. 63:5; ISSN 0044-0086
Country of Publication:
United States
Language:
English